{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:05:13Z","timestamp":1792037113618,"version":"4.4.0"},"reference-count":100,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Glucagon-like peptide-1 (GLP-1) analogues are a major class of peptide therapeutics used to treat metabolic diseases. GLP-1-derived peptides are characterized by dynamic conformational ensembles in which folding, intermolecular assembly, and aggregation are strictly coupled processes. This study focused on the effects of sequence modifications, such as helix-promoting residues and backbone constraints on the helix-coil equilibrium, as well as lipidation, which creates competing equilibria among monomeric, oligomeric, and albumin-bound forms. These coupled equilibria simultaneously enhance pharmacokinetic properties and modulate conformational stability. We also explored how environmental conditions such as ionic concentration and temperature affect conformation, and emphasize how manufacturing processes act as external perturbations that could impact structural integrity. Moreover, we focus on the increasingly emerging new multi-agonist peptides, noting that their increased sequence complexity broadens conformational diversity and poses challenges to existing design methods. Despite significant experimental progress, predictive models capable of mapping the intricate interconnections among peptide sequences, lipidation patterns, and aggregation pathways remain critically limited. This highlights the importance of integrating biophysics, computation, and process science. The review points out that designing effective GLP-1 therapeutics rationally depends on managing conformational distributions across complex energy landscapes, not just stabilizing individual structures, in order to offer a new framework for developing the next generation of peptide drugs.<\/jats:p>","DOI":"10.3390\/molecules31152556","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:11:42Z","timestamp":1784787102000},"page":"2556","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structural Dynamics of GLP-1 Analogues: Folding Energetics, Lipidation-Driven Assembly, and Aggregation Mechanisms"],"prefix":"10.3390","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9690-907X","authenticated-orcid":false,"given":"Angelo","family":"Santoro","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Macis","sequence":"additional","affiliation":[{"name":"Fresenius Kabi iPSUM, Via San Leonardo, 23, 45010 Villadose, Rovigo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"D\u2019Ursi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-5852","authenticated-orcid":false,"given":"Antonio","family":"Ricci","sequence":"additional","affiliation":[{"name":"Fresenius Kabi iPSUM, Via San Leonardo, 23, 45010 Villadose, Rovigo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S2468-1253(24)00188-2","article-title":"Gastrointestinal effects of GLP-1 receptor agonists: Mechanisms, management, and future directions","volume":"9","author":"Jalleh","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1111\/1541-4337.12808","article-title":"Slow digestion-oriented dietary strategy to sustain the secretion of GLP-1 for improved glucose homeostasis","volume":"20","author":"Qin","year":"2021","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/00207454.2021.1924707","article-title":"The pleiotropic of GLP-1\/GLP-1R axis in central nervous system diseases","volume":"133","author":"Zhang","year":"2023","journal-title":"Int. J. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.peptides.2017.10.011","article-title":"Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes","volume":"100","author":"Deacon","year":"2018","journal-title":"Peptides"},{"key":"ref_7","first-page":"212283","article-title":"A clinical review of GLP-1 receptor agonists: Efficacy and safety in diabetes and beyond","volume":"4","author":"Isaacs","year":"2015","journal-title":"Drugs Context"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1021\/acs.jpcb.4c01794","article-title":"Energy Landscapes and Structural Ensembles of Glucagon-like Peptide-1 Monomers","volume":"128","author":"Keith","year":"2024","journal-title":"J. Phys. Chem. B"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41467-021-27760-0","article-title":"Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation","volume":"13","author":"Deganutti","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1021\/bi00178a009","article-title":"Structure of glucagon-like peptide (7-36) amide in a dodecylphosphocholine micelle as determined by 2D NMR","volume":"33","author":"Thornton","year":"1994","journal-title":"Biochemistry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1074\/jbc.M109.033829","article-title":"Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor","volume":"285","author":"Underwood","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13188","DOI":"10.1021\/bi010902s","article-title":"Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states","volume":"40","author":"Neidigh","year":"2001","journal-title":"Biochemistry"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Santoro, A., Ricci, A., Rodriquez, M., Buonocore, M., and D\u2019Ursi, A.M. (2025). A structural effect of the antioxidant curcuminoids on the A\u03b2 (1\u201342) amyloid peptide. Antioxidants, 14.","DOI":"10.3390\/antiox14010053"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s12276-025-01497-y","article-title":"Structural insights into GPCR signaling activated by peptide ligands: From molecular mechanism to therapeutic application","volume":"57","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature22394","article-title":"Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein","volume":"546","author":"Zhang","year":"2017","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41589-021-00945-w","article-title":"Structural and functional diversity among agonist-bound states of the GLP-1 receptor","volume":"18","author":"Cary","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1021\/jm00026a001","article-title":"Computational methods to predict binding free energy in ligand-receptor complexes","volume":"38","author":"Murcko","year":"1995","journal-title":"J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10822-011-9453-x","article-title":"Free energy calculations offer insights into the influence of receptor flexibility on ligand\u2013receptor binding affinities","volume":"25","author":"Dolenc","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Knudsen, L.B., and Lau, J. (2019). The discovery and development of liraglutide and semaglutide. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00155"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"He, M., Cheng, K.F., VanPatten, S., Torres, M.D.T., Al Jabari, B., Mughrabi, I.T., Ballar\u00edn-Gonz\u00e1lez, B., Son, M., de la Fuente-Nunez, C., and Al-Abed, Y. (2025). Protease-Resistant Azapeptide GLP-1 Analogue Improves Metabolic Control in Diet-Induced Obesity. bioRxiv.","DOI":"10.1101\/2025.05.09.653092"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1021\/jp963339+","article-title":"Conformational properties of \u03b1-amino acids disubstituted at the \u03b1-carbon","volume":"101","year":"1997","journal-title":"J. Phys. Chem. B"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1021\/acs.bioconjchem.4c00484","article-title":"Effect of lipidation on the structure, oligomerization, and aggregation of glucagon-like peptide 1","volume":"36","author":"Edu","year":"2025","journal-title":"Bioconjug. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1021\/acs.jmedchem.5c02390","article-title":"Fatty Acid-Conjugated Antimicrobial Peptides: Advances in Design, Activity, and Therapeutic Potential","volume":"69","author":"Helmy","year":"2026","journal-title":"J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1039\/D5SM00801H","article-title":"Observation of unique stable nano-assemblies of a lipidated glucagon-like peptide 1 analogue","volume":"21","author":"Brichtova","year":"2025","journal-title":"Soft Matter"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"20819","DOI":"10.1021\/jacs.5c04095","article-title":"Molecular Design of Unimolecular Tetra-Receptor Agonists","volume":"147","author":"Dinsmore","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"170939","DOI":"10.1016\/j.peptides.2023.170939","article-title":"An update on peptide-based therapies for type 2 diabetes and obesity","volume":"161","author":"Bailey","year":"2023","journal-title":"Peptides"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1021\/acs.chemrev.5b00562","article-title":"Protein ensembles: How does nature harness thermodynamic fluctuations for life? The diverse functional roles of conformational ensembles in the cell","volume":"116","author":"Wei","year":"2016","journal-title":"Chem. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/(SICI)1097-0134(19981115)33:3<343::AID-PROT4>3.0.CO;2-B","article-title":"Kinetic steps for \u03b1-helix formation","volume":"33","author":"Bertsch","year":"1998","journal-title":"Proteins"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.0.CO;2-H","article-title":"Development of the multiple sequence approximation within the AGADIR model of \u03b1-helix formation: Comparison with Zimm-Bragg and Lifson-Roig formalisms","volume":"41","author":"Munoz","year":"1997","journal-title":"Biopolymers"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1039\/D2CP05214H","article-title":"Solvent quality and solvent polarity in polypeptides","volume":"25","author":"Foumthuim","year":"2023","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.1021\/acs.chemrev.1c00757","article-title":"Protein design: From the aspect of water solubility and stability","volume":"122","author":"Qing","year":"2022","journal-title":"Chem. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Banahatti, N., and Sharma, G. (2025). Molecular and Computational Characterization of GLP-1 Receptor\u2013Agonist Binding Mechanisms for Rational Therapeutic Design. ChemRxiv.","DOI":"10.26434\/chemrxiv-2025-1dsl1"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41589-023-01400-8","article-title":"Computational design and genetic incorporation of lipidation mimics in living cells","volume":"20","author":"Ding","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.molmet.2013.08.008","article-title":"Peptide lipidation stabilizes structure to enhance biological function","volume":"2","author":"Ward","year":"2013","journal-title":"Mol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1021\/acs.biochem.8b00105","article-title":"\u03b1-Helix or \u03b2-turn? An investigation into N-terminally constrained analogues of glucagon-like peptide 1 (GLP-1) and exendin-4","volume":"57","author":"Oddo","year":"2018","journal-title":"Biochemistry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mrc.880","article-title":"Structure and folding of glucagon-like peptide-1-(7\u201336)-amide in aqueous trifluoroethanol studied by NMR spectroscopy","volume":"39","author":"Chang","year":"2001","journal-title":"Magn. Reson. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-5793(02)02466-3","article-title":"NMR studies of the aggregation of glucagon-like peptide-1: Formation of a symmetric helical dimer","volume":"515","author":"Chang","year":"2002","journal-title":"FEBS Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1021\/ja710446s","article-title":"Role of backbone\u2212 solvent interactions in determining conformational equilibria of intrinsically disordered proteins","volume":"130","author":"Tran","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s10955-011-0313-9","article-title":"Hydrophobic and ionic-interactions in bulk and confined water with implications for collapse and folding of proteins","volume":"145","author":"Vaitheeswaran","year":"2011","journal-title":"J. Stat. Phys."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/S003358359800345X","article-title":"Trifluoroethanol and colleagues: Cosolvents come of age. Recent studies with peptides and proteins","volume":"31","author":"Buck","year":"1998","journal-title":"Q. Rev. Biophys."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1039\/D0CP05103A","article-title":"Two different regimes in alcohol-induced coil\u2013helix transition: Effects of 2, 2, 2-trifluoroethanol on proteins being either independent of or enhanced by solvent structural fluctuations","volume":"23","author":"Ohgi","year":"2021","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Santoro, A., Buonocore, M., Grimaldi, M., Napolitano, E., and D\u2019Ursi, A.M. (2023). Monitoring the Conformational Changes of the A\u03b2 (25\u221235) Peptide in SDS Micelles: A Matter of Time. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24020971"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Sawyer, J.R., Audie, J.A., Swanson, J., Diller, D., Santiago, S., Gribkoff, V.K., Ackerman, A., Hruby, V.J., Gobbo, G., and Bellucci, M.A. (2024). Design, Structure\u2013Activity Relationships, and Computational Modeling Studies of a Series of \u03b1-Helix Biased, Ultra-Short Glucagon-like Peptide-1 Receptor Agonists. Molecules, 30.","DOI":"10.3390\/molecules30010012"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1021\/bi971937o","article-title":"Enhanced protein thermostability by Ala \u2192 Aib replacement","volume":"37","author":"Frigo","year":"1998","journal-title":"Biochemistry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/cbdv.200890112","article-title":"Aib residues in peptaibiotics and synthetic sequences: Analysis of nonhelical conformations","volume":"5","author":"Aravinda","year":"2008","journal-title":"Chem. Biodivers."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2174\/1381612826666201118094502","article-title":"Drug design of GLP-1 receptor agonists: Importance of in silico methods","volume":"27","author":"Sharma","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Jacobsen, M.T., Poulsen, C., Kopp, K.L., Olsen, J., and Cox, N. (2025). A Survey and Guide to the Development of Fatty Acid-derivatized Peptide Therapeutics. Pept. Sci., 203\u2013268.","DOI":"10.1002\/9781119824701.ch07"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Podder, D., Stala, O., Miah, A., Agyapong, A., Moore, M.E., Hirani, R., Diegisser, D., Garcia, V., and Etienne, M. (2026). Incretin-Based Multi-Agonist Therapies for Type 2 Diabetes Mellitus and Obesity: Mechanisms, Clinical Efficacy, and Future Directions. Diabetology, 7.","DOI":"10.3390\/diabetology7030046"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Rega, M., Petraglia, F.M., D\u2019Ursi, L., Buonocore, M., Criscuolo, D., and Santoro, A. (2026). The Bioenergetic Architecture of Metabolic Regulation: From Gut\u2013Brain Signalling to Next-Generation Peptide Pharmacology. Clin. Bioenerg., 2.","DOI":"10.3390\/clinbioenerg2010005"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e2116506119","DOI":"10.1073\/pnas.2116506119","article-title":"Structural determinants of dual incretin receptor agonism by tirzepatide","volume":"119","author":"Sun","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"146141","DOI":"10.1016\/j.ijbiomac.2025.146141","article-title":"Understanding the activation mechanism of GLP-1R\/GIPR by dual agonist Tirzepatide via molecular dynamics and protein-peptide binding","volume":"321","author":"Zou","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7434","DOI":"10.1021\/acs.jmedchem.7b00787","article-title":"Peptide half-life extension: Divalent, small-molecule albumin interactions direct the systemic properties of glucagon-like peptide 1 (GLP-1) analogues","volume":"60","author":"Bech","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41573-022-00529-w","article-title":"Derivatization with fatty acids in peptide and protein drug discovery","volume":"22","author":"Kurtzhals","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/psc.2890","article-title":"Innovative chemical synthesis and conformational hints on the lipopeptide liraglutide","volume":"22","author":"Guryanov","year":"2016","journal-title":"J. Pept. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"10122","DOI":"10.1039\/D0SM01011A","article-title":"A spectroscopic and molecular dynamics study on the aggregation process of a long-acting lipidated therapeutic peptide: The case of semaglutide","volume":"16","author":"Venanzi","year":"2020","journal-title":"Soft Matter"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.bpj.2015.07.051","article-title":"Oligomerization of a glucagon-like peptide 1 analog: Bridging experiment and simulations","volume":"109","author":"Frederiksen","year":"2015","journal-title":"Biophys. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"107456","DOI":"10.1016\/j.bpc.2025.107456","article-title":"Effects of perturbation of the hydrophobic coiled-coil core on the thermal transition process of \u03b1-helical self-assembling peptides with \u03b1-\u03b2 conformational transition capability","volume":"323","author":"Kurokawa","year":"2025","journal-title":"Biophys. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1359-0278(96)00009-0","article-title":"Stabilization of proteins by rational design of \u03b1-helix stability using helix\/coil transition theory","volume":"1","author":"Villegas","year":"1996","journal-title":"Fold. Des."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1021\/ar700264k","article-title":"A hydrogen bond surrogate approach for stabilization of short peptide sequences in \u03b1-helical conformation","volume":"41","author":"Patgiri","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10930-009-9201-4","article-title":"Intrinsically disordered proteins and their environment: Effects of strong denaturants, temperature, pH, counter ions, membranes, binding partners, osmolytes, and macromolecular crowding","volume":"28","author":"Uversky","year":"2009","journal-title":"Protein J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10858-011-9472-x","article-title":"Random coil chemical shift for intrinsically disordered proteins: Effects of temperature and pH","volume":"49","author":"Kjaergaard","year":"2011","journal-title":"J. Biomol. NMR"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"114566","DOI":"10.1016\/j.jpba.2021.114566","article-title":"Oligomerization, albumin binding and catabolism of therapeutic peptides in the subcutaneous compartment: An investigation on lipidated GLP-1 analogs","volume":"210","author":"Gallo","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.2174\/092986609789839232","article-title":"Amyloidogenicity and aggregate cytotoxicity of human glucagon-like peptide-1 (hGLP-1)","volume":"16","author":"Poon","year":"2009","journal-title":"Protein Pept. Lett."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Duan, L., Yang, Y., Wu, H., Ding, X., and Jiang, M. (2025). Effects of pH and Salts on the Aggregation State of Semaglutide and Membrane Filtration Performance. Separations, 13.","DOI":"10.3390\/separations13010015"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"106374","DOI":"10.1016\/j.ejps.2023.106374","article-title":"Advances in formulation and manufacturing strategies for the delivery of therapeutic proteins and peptides in orally disintegrating dosage forms","volume":"182","author":"Bashir","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e70039","DOI":"10.1002\/psc.70039","article-title":"Influence of Buffering Capacity, pH, and Temperature on the Stability of Semaglutide: A Preformulation Study","volume":"31","author":"Malgave","year":"2025","journal-title":"J. Pept. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Lui, L.H., Egbu, R., Graver, T., Williams, G.R., Brocchini, S., and Velayudhan, A. (2022). Computational and Experimental Evaluation of the Stability of a GLP-1-like Peptide in Ethanol\u2013Water Mixtures. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14071462"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"184420","DOI":"10.1016\/j.bbamem.2025.184420","article-title":"Effect of osmolytes on the conformational stability of A\u03b2 (25\u201335): A circular dichroism analysis","volume":"1867","author":"Santoro","year":"2025","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Skaanning, L.K., Santoro, A., Skamris, T., Martinsen, J.H., D\u2019Ursi, A.M., Bucciarelli, S., Vestergaard, B., Bugge, K., Langkilde, A.E., and Kragelund, B.B. (2020). The non-fibrillating N-terminal of \u03b1-synuclein binds and co-fibrillates with heparin. Biomolecules, 10.","DOI":"10.3390\/biom10081192"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41573-020-0062-z","article-title":"Advances in therapeutic peptides targeting G protein-coupled receptors","volume":"19","author":"Davenport","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e11568","DOI":"10.1016\/j.heliyon.2022.e11568","article-title":"Structural analysis of a simplified model reproducing SARS-CoV-2 S RBD\/ACE2 binding site","volume":"8","author":"Buonocore","year":"2022","journal-title":"Heliyon"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"116871","DOI":"10.1016\/j.ejmech.2024.116871","article-title":"Peptides as modulators of FPPS enzyme: A multifaceted evaluation from the design to the mechanism of action","volume":"279","author":"Covelli","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"109374","DOI":"10.1016\/j.celrep.2021.109374","article-title":"Structure and dynamics of semaglutide-and taspoglutide-bound GLP-1R-Gs complexes","volume":"36","author":"Zhang","year":"2021","journal-title":"Cell Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41421-024-00700-0","article-title":"Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide","volume":"10","author":"Li","year":"2024","journal-title":"Cell Discov."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1021\/jm9909645","article-title":"Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration","volume":"43","author":"Knudsen","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1021\/acs.oprd.4c00515","article-title":"Improving Solid-State Properties of the Side-Chain Peptide Building Blocks for the Synthesis of GLP-1 Analogs through Their Complexation with Metal Cations","volume":"29","author":"Orlandin","year":"2025","journal-title":"Org. Process Res. Dev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/mp500519s","article-title":"Transformation of oligomers of lipidated peptide induced by change in pH","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Pharm."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1080\/07391102.2025.2532848","article-title":"Molecular dynamics insights into the binding interactions of semaglutide with human serum albumin","volume":"44","author":"Liu","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Weiskirchen, R., and Lonardo, A. (2025). Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver Disorders. Med. Sci., 13.","DOI":"10.20944\/preprints202510.2102.v1"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e24340","DOI":"10.1016\/j.heliyon.2024.e24340","article-title":"Exploring a novel long-acting glucagon-like peptide-1 receptor agonist built on the albumin-binding domain and XTEN scaffolds","volume":"10","author":"Zhou","year":"2024","journal-title":"Heliyon"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/bip.22474","article-title":"A GLP-1 receptor agonist conjugated to an albumin-binding domain for extended half-life","volume":"102","author":"Lindgren","year":"2014","journal-title":"Pept. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4103\/2230-8210.111625","article-title":"Glucagon-like peptide-1 analogues: An overview","volume":"17","author":"Gupta","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1016\/j.csbj.2025.11.007","article-title":"In silico investigations of albumin-GLP-1 receptor agonist complexes for diabetes drug delivery applications","volume":"27","author":"Murphy","year":"2025","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Marassi, V., Macis, M., Giordani, S., Ferrazzano, L., Tolomelli, A., Roda, B., Zattoni, A., Ricci, A., Reschiglian, P., and Cabri, W. (2022). Application of Af4-multidetection to liraglutide in its formulation: Preserving and representing native aggregation. Molecules, 27.","DOI":"10.3390\/molecules27175485"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41467-022-28683-0","article-title":"Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Katsi, V., Koutsopoulos, G., Fragoulis, C., Dimitriadis, K., and Tsioufis, K. (2025). Retatrutide\u2014A game changer in obesity pharmacotherapy. Biomolecules, 15.","DOI":"10.3390\/biom15060796"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/joim.12837","article-title":"Peptide-based multi-agonists: A new paradigm in metabolic pharmacology","volume":"284","author":"Brandt","year":"2018","journal-title":"J. Intern. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"16757","DOI":"10.1021\/acs.jmedchem.4c01553","article-title":"Influence of Trp-Cage on the Function and Stability of GLP-1R Agonist Exenatide Derivatives","volume":"67","author":"Taricska","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"111223","DOI":"10.1016\/j.jbc.2026.111223","article-title":"Co-solute Effects Reveal the Nature of Weak Forces Governing GLP-1 Oligomers Stability","volume":"302","author":"Settle","year":"2026","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1021\/acscentsci.5c00431","article-title":"Revealing anisotropic growth of liraglutide oligomers by native ion mobility mass spectrometry and molecular dynamics simulation","volume":"11","author":"Xi","year":"2025","journal-title":"ACS Cent. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"13465","DOI":"10.1021\/acs.analchem.5c01851","article-title":"Dissecting Hidden Liraglutide Oligomerization Pathways via Direct Mass Technology, Electron-Capture Dissociation, and Molecular Dynamics","volume":"97","author":"Kuo","year":"2025","journal-title":"Anal. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"16791","DOI":"10.1021\/acssuschemeng.4c07543","article-title":"A Sustainable Chemo-Enzymatic Approach to the Synthesis of Liraglutide","volume":"12","author":"Rizzo","year":"2024","journal-title":"ACS Sustain. Chem. Eng."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/acs.oprd.1c00021","article-title":"Copper (II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists liraglutide and semaglutide","volume":"25","author":"Guryanov","year":"2021","journal-title":"Org. Process Res. Dev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"107120","DOI":"10.1016\/j.ejps.2025.107120","article-title":"Comparing the performance of electrostatic repulsion-reversed phase chromatography approaches in the resolution of complex peptide mixture: Liraglutide as case study","volume":"211","author":"Manetto","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1021\/acs.molpharmaceut.4c00038","article-title":"Understanding Glucagon Aggregation: In Silico Insights and Experimental Validation","volume":"21","author":"Pisano","year":"2024","journal-title":"Mol. Pharm."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Grimaldi, M., Santoro, A., Buonocore, M., Crivaro, C., Funicello, N., Saponetti, M.S., Ripoli, C., Rodriquez, M., De Pasquale, S., and Bobba, F. (2022). A new approach to supramolecular structure determination in pharmaceutical preparation of self-assembling peptides: A case study of lanreotide Autogel. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14030681"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/oby.70106","article-title":"Weekly Subcutaneous VK2735, a GIP\/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study","volume":"34","author":"Bays","year":"2026","journal-title":"Obesity"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/dom.70006","article-title":"Efficacy and safety of CT-868, a novel, fully biased, dual glucagon-like peptide-1\/glucose-dependent insulinotropic polypeptide receptor agonist, in type 2 diabetes: A double-blind, randomized placebo controlled phase 2 trial","volume":"28","author":"Chakravarthy","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1111\/dom.70822","article-title":"Beyond GLP-1 Monotherapy: Novel Multi-Agonists, Amylin Analogues, and Combination Strategies in Obesity and Type 2 Diabetes","volume":"28","author":"Khachaturov","year":"2026","journal-title":"Diabetes Obes. Metab."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/15\/2556\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:12:00Z","timestamp":1784787120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/15\/2556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":100,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["molecules31152556"],"URL":"https:\/\/doi.org\/10.3390\/molecules31152556","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}